These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31885861)

  • 1. Recent advances in understanding the phenotypes of osteoarthritis.
    Mobasheri A; Saarakkala S; Finnilä M; Karsdal MA; Bay-Jensen AC; van Spil WE
    F1000Res; 2019; 8():. PubMed ID: 31885861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: biochemical markers associated with emerging clinical phenotypes and molecular endotypes.
    Mobasheri A; van Spil WE; Budd E; Uzieliene I; Bernotiene E; Bay-Jensen AC; Larkin J; Levesque MC; Gualillo O; Henrotin Y
    Curr Opin Rheumatol; 2019 Jan; 31(1):80-89. PubMed ID: 30461544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble biochemical markers of osteoarthritis: Are we close to using them in clinical practice?
    Mobasheri A; Bay-Jensen AC; Gualillo O; Larkin J; Levesque MC; Henrotin Y
    Best Pract Res Clin Rheumatol; 2017 Oct; 31(5):705-720. PubMed ID: 30509415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From biochemical markers to molecular endotypes of osteoarthritis: a review on validated biomarkers.
    Hannani MT; Thudium CS; Karsdal MA; Ladel C; Mobasheri A; Uebelhoer M; Larkin J; Bacardit J; Struglics A; Bay-Jensen AC
    Expert Rev Mol Diagn; 2024; 24(1-2):23-38. PubMed ID: 38353446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoarthritis--a case for personalized health care?
    Karsdal MA; Christiansen C; Ladel C; Henriksen K; Kraus VB; Bay-Jensen AC
    Osteoarthritis Cartilage; 2014 Jan; 22(1):7-16. PubMed ID: 24216058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can metabolic profiling provide a new description of osteoarthritis and enable a personalised medicine approach?
    Jaggard MKJ; Boulangé CL; Graça G; Vaghela U; Akhbari P; Bhattacharya R; Williams HRT; Lindon JC; Gupte CM
    Clin Rheumatol; 2020 Dec; 39(12):3875-3882. PubMed ID: 32488772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is osteoarthritis one disease or a collection of many?
    Deveza LA; Loeser RF
    Rheumatology (Oxford); 2018 May; 57(suppl_4):iv34-iv42. PubMed ID: 29267932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoarthritis phenotypes and novel therapeutic targets.
    Van Spil WE; Kubassova O; Boesen M; Bay-Jensen AC; Mobasheri A
    Biochem Pharmacol; 2019 Jul; 165():41-48. PubMed ID: 30831073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for osteoarthritis: Current status and future prospects.
    Mobasheri A; Thudium CS; Bay-Jensen AC; Maleitzke T; Geissler S; Duda GN; Winkler T
    Best Pract Res Clin Rheumatol; 2023 Jun; 37(2):101852. PubMed ID: 37620236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on the pathophysiology of osteoarthritis.
    Mobasheri A; Batt M
    Ann Phys Rehabil Med; 2016 Dec; 59(5-6):333-339. PubMed ID: 27546496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis.
    Kraus VB; Burnett B; Coindreau J; Cottrell S; Eyre D; Gendreau M; Gardiner J; Garnero P; Hardin J; Henrotin Y; Heinegård D; Ko A; Lohmander LS; Matthews G; Menetski J; Moskowitz R; Persiani S; Poole AR; Rousseau JC; Todman M;
    Osteoarthritis Cartilage; 2011 May; 19(5):515-42. PubMed ID: 21396468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Concepts of Endotypes/Phenotypes in Regenerative Medicine for Osteoarthritis.
    Im GI; Moon JY
    Tissue Eng Regen Med; 2022 Apr; 19(2):321-324. PubMed ID: 34674181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital biomarkers of spine and musculoskeletal disease from accelerometers: Defining phenotypes of free-living physical activity in knee osteoarthritis and lumbar spinal stenosis.
    Tomkins-Lane C; Norden J; Sinha A; Hu R; Smuck M
    Spine J; 2019 Jan; 19(1):15-23. PubMed ID: 30025995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?
    Siebuhr AS; Bay-Jensen AC; Jordan JM; Kjelgaard-Petersen CF; Christiansen C; Abramson SB; Attur M; Berenbaum F; Kraus V; Karsdal MA
    Scand J Rheumatol; 2016; 45(2):87-98. PubMed ID: 26484849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypes of osteoarthritis: current state and future implications.
    Deveza LA; Nelson AE; Loeser RF
    Clin Exp Rheumatol; 2019; 37 Suppl 120(5):64-72. PubMed ID: 31621574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoarthritis year 2012 in review: biomarkers.
    Mobasheri A
    Osteoarthritis Cartilage; 2012 Dec; 20(12):1451-64. PubMed ID: 22842200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty.
    Arden N; Richette P; Cooper C; Bruyère O; Abadie E; Branco J; Brandi ML; Berenbaum F; Clerc C; Dennison E; Devogelaer JP; Hochberg M; D'Hooghe P; Herrero-Beaumont G; Kanis JA; Laslop A; Leblanc V; Maggi S; Mautone G; Pelletier JP; Petit-Dop F; Reiter-Niesert S; Rizzoli R; Rovati L; Tajana Messi E; Tsouderos Y; Martel-Pelletier J; Reginster JY
    Drugs Aging; 2015 Jul; 32(7):525-35. PubMed ID: 26085027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria.
    Bay-Jensen AC; Reker D; Kjelgaard-Petersen CF; Mobasheri A; Karsdal MA; Ladel C; Henrotin Y; Thudium CS
    Osteoarthritis Cartilage; 2016 Jan; 24(1):9-20. PubMed ID: 26707988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble biomarkers development in osteoarthritis: from discovery to personalized medicine.
    Henrotin Y; Sanchez C; Cornet A; Van de Put J; Douette P; Gharbi M
    Biomarkers; 2015; 20(8):540-6. PubMed ID: 26954785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics.
    Oo WM; Yu SP; Daniel MS; Hunter DJ
    Expert Opin Emerg Drugs; 2018 Dec; 23(4):331-347. PubMed ID: 30415584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.